InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-38.8%
Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Domzalski David, Chairman & CEO. Insider active across 1 company, notably VYNE Therapeutics Inc.. Cumulatively, 33 reports have been recorded. Activity tracked since 28 May 2021. The latest transaction was disclosed on 31 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations33 total
30,498 shares@ US$1.5811.0% of flowCommon StockSEC:0001415889-25-009629:0
24,536 shares@ US$3.3519.6% of flowCommon StockSEC:0001415889-25-000152:0
3,901 shares@ US$2.101.9% of flowCommon StockSEC:0001415889-24-028073:0
685 shares@ US$1.880.3% of flowCommon StockSEC:0001415889-24-024380:0
935 shares@ US$1.920.4% of flowCommon StockSEC:0001415889-24-019173:0
4,429 shares@ US$2.1592.2% of flowCommon StockSEC:0001415889-24-015370:0
1,004 shares@ US$3.080.7% of flowCommon StockSEC:0001415889-24-010064:0
225,000 shares0Common StockSEC:0001209191-24-000465:0
225,000 shares0Common StockSEC:0001209191-23-058815:0
2,284 shares@ US$2.81351.5% of flowCommon StockSEC:0001209191-23-057220:0
8,549 shares@ US$3.837.7% of flowCommon StockSEC:0001209191-23-051941:0
981 shares@ US$4.100.9% of flowCommon StockSEC:0001209191-23-041094:0
2,766 shares@ US$3.45632.2% of flowCommon StockSEC:0001209191-23-033783:0
2,734 shares@ US$3.081.9% of flowCommon StockSEC:0001209191-23-022790:0
10,685 shares@ US$0.150.4% of flowCommon StockSEC:0001209191-23-001066:0
34,705 shares@ US$0.19771.6% of flowCommon StockSEC:0001209191-22-059425:0
10,683 shares@ US$0.2230.6% of flowCommon StockSEC:0001209191-22-052350:0
10,683 shares@ US$0.3891.0% of flowCommon StockSEC:0001209191-22-040778:0
11,887 shares@ US$0.34630.020% mcap2.1% of flowCommon StockSEC:0001209191-22-033542:0
23,186 shares@ US$0.650.070% mcap7.3% of flowCommon StockSEC:0001209191-22-022523:0
312,302 shares0Common StockSEC:0001209191-22-020064:0
6,887 shares@ US$1.021.5% of flowCommon StockSEC:0001209191-22-000852
6,887 shares@ US$1.020.032% mcap3.3% of flowCommon StockSEC:0001209191-22-000852:0
4,705 shares@ US$0.87550.019% mcap2.0% of flowCommon StockSEC:0001209191-21-067646:0
4,705 shares@ US$0.87550.9% of flowCommon StockSEC:0001209191-21-067646
25 of 33 declarations
About Domzalski David
David Domzalski is an executive at VYNE Therapeutics Inc.
